Silvestrini, Ana Vitória Pupo 
; Debiasi, Bryan Wender; Praça, Fabíola ; Bentley, Maria Vitória Lopes Badra
Source: International Journal of Pharmaceutics. Unidade: FCFRP
Subjects: CRISTAIS LÍQUIDOS, NANOPARTÍCULAS, ÁCIDOS NUCLEICOS, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRINI, Ana Vitória Pupo et al. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics, v. 628, p. 1-23, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122299. Acesso em: 24 dez. 2025.APA
Silvestrini, A. V. P., Debiasi, B. W., Praça, F., & Bentley, M. V. L. B. (2022). Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics, 628, 1-23. doi:10.1016/j.ijpharm.2022.122299NLM
Silvestrini AVP, Debiasi BW, Praça F, Bentley MVLB. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies [Internet]. International Journal of Pharmaceutics. 2022 ; 628 1-23.[citado 2025 dez. 24 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122299Vancouver
Silvestrini AVP, Debiasi BW, Praça F, Bentley MVLB. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies [Internet]. International Journal of Pharmaceutics. 2022 ; 628 1-23.[citado 2025 dez. 24 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122299
